Dld Asset Management, LP Leap Therapeutics, Inc. Transaction History

Dld Asset Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.96 - $1.91 $240,000 - $477,500	250,000 Added 100.0%	500,000 $575,000
Q1 2022 May 13, 2022	SELL	$1.6 - $3.35 $192,000 - $402,000	-120,000 Reduced 32.43%	250,000 $438,000
Q4 2021 Feb 14, 2022	BUY	$2.08 - $3.65 $769,600 - $1.35 Million	370,000 New	370,000 $1.2 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.